Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status

被引：13

作者：

Bhayani, SB ^{[1
]}

Allaf, ME ^{[1
]}

Kavoussi, LR ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Baltimore, MD 21287 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2004年 / 22卷 / 02期

关键词：

testis cancer; lymphadenectomy; retroperitoneal lymph node dissection; germ cell tumor;

D O I：

10.1016/j.urolonc.2004.01.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：145 / 148

页数：4

共 50 条

[31] Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial
Albers, P
Siener, R
Kliesch, S
Weissbach, L
Krege, S
Sparwasser, C
Schulze, H
Heidenreich, A
de Riese, W
Loy, V
Bierhoff, E
Wittekind, C
Fimmers, R
Hartmann, M
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1505 - 1512
[32] Surgical management of low-stage nonseminomatous germ cell testicular cancer
Stephenson, Andrew J.
Klein, Eric A.
BJU INTERNATIONAL, 2009, 104 (9B) : 1362 - 1368
[33] Management of patients with low-stage nonseminomatous germ cell testicular cancer
Stephenson A.J.
Sheinfeld J.
Current Treatment Options in Oncology, 2005, 6 (5) : 367 - 377
[34] Serum lactate dehydrogenase isoenzyme I and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I
von Eyben, FE
Madsen, EL
Blaabjerg, O
Petersen, PH
von der Maase, H
Jacobsen, GK
Rorth, M
ACTA ONCOLOGICA, 2001, 40 (04) : 536 - 540
[35] SURVEILLANCE IN PATIENTS WITH STAGE-I TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS
GEZ, E
WYGODA, M
NUSSBAUM, N
FIGER, A
GIL, RI
INBAL, M
CANCER INVESTIGATION, 1993, 11 (01) : 10 - 14
[36] ORCHIECTOMY ALONE IN STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
GELDERMAN, WAH
KOOPS, HS
SLEIJFER, DT
OOSTERHUIS, JW
MARRINK, J
DEBRUIJN, HWA
OLDHOFF, J
CANCER, 1987, 59 (03) : 578 - 580
[37] The oncological efficacy of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical stage I nonseminomatous germ cell testis cancer
Lima, G
Nielsen, ME
Porter, J
Cadeddu, JA
Tuerk, I
Kavoussi, LR
JOURNAL OF UROLOGY, 2006, 175 (04): : 190 - 190
[38] Risk Stratification of Pubertal Children and Postpubertal Adolescents with Clinical Stage I Testicular Nonseminomatous Germ Cell Tumors
Cost, Nicholas G.
Lubahn, Jessica D.
Adibi, Mehrad
Romman, Adam
Wickiser, Jonathan E.
Raj, Ganesh V.
Sagalowsky, Arthur I.
Margulis, Vitaly
JOURNAL OF UROLOGY, 2014, 191 (05): : 1485 - 1490
[39] LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL CANCER (NSGCC). ANALYSIS OF 178 CASES
Rioja Zuazu, J. P.
Vidal-Moral, I.
Ramos-Barcelo, E.
Laguna-Pes, M. P.
Castillo Cadiz, O. A.
EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 236 - 236
[40] Automated image analysis DNA cytometry to predict the pathological stage in clinical stage I nonseminomatous testicular germ cell tumors
Albers, P
Burger, RA
Braun, MH
Fichtner, J
Fisch, M
Stockle, M
EUROPEAN UROLOGY, 1997, 31 (03) : 356 - 359

← 1 2 3 4 5 →